Background: Direct detection of the gene mutation allows for the confirmati
on of the clinical diagnosis of Machado-Joseph disease (MJD), the most freq
uent cause of autosomal dominant spinocerebellar ataxia worldwide.
Objective: To address the main difficulties in our national MJD predictive
testing program. The first was the emergence of intermediate alleles, for w
hich it is not yet possible to determine whether they will cause disease. T
he second was the issue of homoallelism, ie, homozygosity for 2 normal alle
les with exactly the same (CAG)(n) length, which occurs in about 10% of all
test results.
Methods: A large pedigree with 1 affected patient carrying a 71 and a 51 CA
G repeat and 2 asymptomatic relatives carrying the 51 CAG repeat and normal
-size alleles underwent clinical and molecular studies. Intragenic haplotyp
es for these alleles were determined, A representative sample of the health
y population in the region was obtained to assess the distribution of the n
ormal (CAG), length. We established the genotype for 4 intragenic polymorph
isms in the gene for MJD (MJD1) in 21 homoallelic individuals, to distingui
sh their 2 normal chromosomes. In addition, we developed a new Southern blo
t method to completely exclude cases of nonamplification of expanded allele
s in the homoallelic individuals.
Results: The study of the family in which the 51 CAG repeat was found sugge
sts that the allele is apparently associated with disease. These intermedia
te alleles were not present in a large sample of the healthy from the same
region. Intragenic polymorphisms allowed distinction of the 2 different nor
mal alleles in cases of homoallelism, The absence of an expanded allele was
also confirmed by Southern blot.
Conclusions: We propose an improved protocol for molecular testing for MJD.
These strategies, developed to overcome the practical difficulties mostly
in the presymptomatic and prenatal diagnosis of MJD, should useful for othe
r polyglutamine -related disorders.